Dr. Weiner’s blog will return in September.
|
|
Pediatric Cancer Survivorship Specialist Joins Georgetown Lombardi
Recently, Georgetown Lombardi welcomed Nina Kadan-Lottick, MD, MSPH, as a professor of oncology and pediatrics, member of the Cancer Prevention and Control Program, and Director of the Survivorship Research Initiative. Kadan-Lottick has focused her work on improving outcomes in children, adolescents, and young adults with cancer, particularly after the end of their treatment. She joins Georgetown from Yale University School of Medicine, where she was a research scientist in pediatric hematology/oncology and founder and medical director of the HEROS Program, a multidisciplinary research and clinical program for long-term childhood cancer survivors that was one of the first of its kind in the country. She serves on the Children’s Oncology Group Executive Council and helped to co-author the Children’s Oncology Group Long-Term Follow-up Guidelines. She is currently the PI of two NCI-funded randomized control trials in childhood, adolescent and young adult childhood cancer survivors to improve physical activity and adherence to recommended surveillance for late complications of therapy.
|
|
Kowalczyk Named Interim Chair for Urology Department
Keith Kowalczyk, MD (M’05), has been named interim physician executive director, MedStar Washington Urology Service Line; interim chief of service, Department of Urology at MedStar Georgetown University Hospital; and recommended for interim academic chair of the Department of Urology at Georgetown University School of Medicine. Kowalczyk succeeds John Lynch, MD, who will remain with MedStar Health in an advisory role through December. A mentee of Lynch’s, Kowalczyk is a practicing urologic oncologist, associate professor at the School of Medicine, and director of urologic oncology in the Department of Urology at MedStar Georgetown University Hospital.
|
|
Larson to Chair Dermatology Department
Allison Larson, MD, MS, has been named the physician executive director of the MedStar Dermatology Service Line, academic chair of the Department of Dermatology at Georgetown University School of Medicine, and chair of the Department of Dermatology at MedStar Washington Hospital Center. Larson joins Georgetown starting October 1 from Boston University School of Medicine, where she is vice chair for education, residency program director, chair of the residency advisory committee, and a member of the Boston Medical Center women’s leadership advisory committee.
|
|
The Ruesch Center for the Cure of Gastrointestinal Cancers recently released the summer 2021 issue of its e-newsletter, The Ruesch Report. This issue includes a look at socioeconomic status and cancer outcome disparities, a summary of what Ruesch researchers presented at this year’s ASCO Annual Meeting, as well as what they found interesting, and highlights from the sixth-annual GI Cancer Patient Summit. Subscribe to the Ruesch Report to receive it via e-mail.
|
|
Monday, August 9
2:00 - 3:00 p.m.
Learn how to upload your CV, add your personal website information, upload a syllabus, publications and more. Register for this class.
|
|
Summer Seminar Series in Cancer Biology
Tuesday, August 10
1:00 - 2:00 p.m.
This lecture series showcases Georgetown Lombardi research. Paul D. Leger, MD, MPH, medical oncologist at MedStar Georgetown University Hospital, presents “Translating Cancer Biology Into Patient Care.” Join this lecture via Zoom.
|
|
Wednesday, August 11
12:00 - 1:00 p.m.
This session of the GHUCCTS Regulatory, Ethics, Knowledge & Support (REKS) summer webinar series on “Pathways to Decentralized (Virtual) Clinical Trials” features Heidi Maloni, PhD, national clinical director, Multiple Sclerosis Centers of Excellence - East, Washington DC VA Medical Center, U.S. Department of Veterans Affairs, discussing “Using Telehealth Technology for Virtual Clinical Trial Visits.” Register for this webinar.
|
|
Friday and Saturday, November 19 - 20
Topics include expanding I/O therapies in GI cancer, targeted therapies in GI cancer, and health disparities in GI cancer.
|
|
Funding and Award Opportunities
NIH AI for Drug Development Funding Opportunity
National Institute of Drug Abuse (NIDA is looking to foster research utilizing artificial intelligence tools in Substance Use Disorder (SUD) drug discovery and development. This single submission date funding opportunity, “Leveraging Artificial Intelligence (AI) Tools for Substance Use Disorders (SUD) Drug Discovery and Development,” is provided via the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding programs. Funding ranges between $150K and $2.8M. Application Due Date: August 10. View more information and access application portal:
_______________________________
Gabrielle's Angel Foundation 2021 Medical Research Awards
Gabrielle’s Angel Foundation funds promising physician scientists who are applying novel and state-of-the-art techniques to address fundamental problems in the genesis and treatment of blood related cancers. Applications for this year’s grants are welcome from two junior faculty members at Georgetown Lombardi – one who is conducting mainstream or conventional research and one who is conducting complementary or integrative research. Projects will be funded for a three-year period at $75,000.00 per year. View grant guidelines and application. Electronic grant submission must be received by Friday, August 27; three hard copies of the application must be postmarked by that date as well.
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | Elizabeth Earle – 5FU pumps/Neulasta/infusion issues; Vince Yeung and Dr. Philips – Journal Club: CheckMate 274 | Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 87757)
12:15 PM | Dr. Perry (WHC) – Metastatic Pancreatic Cancer | Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 98690314696; CME code: 87724)
|
|
8:00 AM | Thoracic Tumor Board - Thoracic Fellow | Podium A / Zoom
9:00 AM | Thoracic Research Meeting - Thoracic Fellow | Podium A / Microsoft Teams
12:15 PM | Dr. Catlett (WHC) – Smear Review | Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
|
|
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | Board Review / IT tips for fellows / TBD | Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:15 PM | No Lecture | Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
1:00 PM | Pancreas Tumor Boar d | 2 PHC / WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
Connect with Lombardi on Social Media
|
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
